Abstract
Dendritic cells (DCs) are special subsets of antigen-presenting cells characterized by their highly potent capacity to activate immunologically naive T cells. Here we report that DCs that are transfected with CD95 ligand (CD95L) cDNA, called 'killer' DCs, deliver death signals, instead of activation signals, to T cells after antigen-specific interaction. Injection of antigen-pulsed killer DCs into mice before sensitization induced antigen-specific immunosuppression. When administered after sensitization, killer DCs suppressed immune responses almost completely after subsequent challenge. Thus, killer DCs represent an entirely new immunomodulatory protocol, which may become directly applicable in preventing and even treating T cell-mediated inflammatory diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Banchereau, J. & Steinman, R.M. Dendritic cells and the control of immunity. Nature 392, 245– 252 (1998).
Steinman, R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9, 271–296 (1991).
Bhardwaj, N. Interactions of viruses with dendritic cells: a double-edged sword. J. Exp. Med. 186, 795–799 (1997).
Johnson, L.L. & Sayles, P.C. Interleukin-12, dendritic cells, and the initiation of host-protective mechanisms against Toxoplasma gondii . J. Exp. Med. 186, 1799– 1802 (1997).
Shurin, M.R. Dendritic cells presenting tumor antigen. Cancer Immunol. Immunother. 43, 158–164 ( 1996).
Chambers, C.A. & Allison, J.P. Co-stimulation in T cell responses. Curr. Opin. Immunol. 9, 396– 404 (1997).
Dhein, J., Walczak, H., Baümler, C., Debatin, K.M. & Krammer, P.H. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373, 438– 441 (1995).
Brunner, T. et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373, 441–444 (1995).
Ju, S.-T. et al. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373, 444 –448 (1995).
Süss, G. & Shortman, K. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand- induced apoptosis. J. Exp. Med. 183, 1789–1796 ( 1996).
Kronin, V., et al. A subclass of Dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production. J. Immunol. 157, 3819–3827 (1996).
Maraskovsky, E. et al. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184, 1953– 1962 (1996).
Ashkenazi, A. & Dixit, V.M. Death receptors: signaling and modulation. Science 281, 1305–1308 (1998).
Schulze-Osthoff, K., Ferrari, D., Los, M., Wesselborg, S. & Peter, M.E. Apoptosis signaling by death receptors. Eur. J. Biochem. 254, 439–459 (1998).
van Parijs, L.V. & Abbas, A.K. Role of Fas-mediated cell death in the regulation of immune responses. Curr. Opin. Immunol. 8, 355–361 ( 1996).
Matiba, B., Mariani, S.M. & Krammer, P.H. The CD95 system and the death of a lymphocyte. Semin. Immunol. 9, 59–68 (1997).
Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A. & Duke, R.C. A role for CD95 ligand in preventing graft rejection. Nature 377, 630–632 (1995).
Griffith, T.S., Brunner, T., Fletcher, S.M., Green, D.R. & Ferguson, T.A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270, 1189–1192 (1995).
Nagata, S. Apoptosis by death factor. Cell 88, 355– 365 (1997).
Xu, S. et al. Successive generation of antigen-presenting, dendritic cell lines from murine epidermis. J Immunol 154, 2697 –2705 (1995).
Xu, S., Ariizumi, K., Edelbaum, D., Bergstresser, P.R. & Takashima, A. Cytokine-dependent regulation of growth and maturation in murine epidermal dendritic cell lines. Eur. J. Immunol. 25, 1018–1024 (1995).
Takashima, A. et al. Colony-stimulating factor-1 secreted by fibroblasts promotes the growth of dendritic cell lines (XS series) derived from murine epidermis. J. Immunol. 154, 5128– 5135 (1995).
Kitajima, T. et al. T cell-mediated terminal maturation of dendritic cells: Loss of adhesive and phagocytotic capacities. J. Immunol. 157, 2340–2347 (1996).
Kitajima, T., Ariizumi, K., Bergstresser, P.R. & Takashima, A. T cell-dependent loss of proliferative responsiveness to colony-stimulating factor-1 by a murine epidermal-derived dendritic cell line, XS52. J. Immunol. 155, 5190–5197 (1995).
Timares, L., Takashima, A. & Johnston, S.A. Quantitative analysis of the immunopotency of genetically transfected dendritic cells. Proc. Natl. Acad. Sci. USA 95, 13147–13152 (1998).
Kayagaki, N. et al. Polymorphism of murine Fas ligand that affects the biological activity. Proc. Natl. Acad. Sci. USA 94, 3914–3919 (1997).
Lu, L. et al. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J. Immunol. 158, 5676–5684 (1997).
Ogasawara, J. et al. Lethal effect of the anti-Fas antibody in mice. Nature 364, 806–809 ( 1993).
Gould, D.S. & Auchincloss, H. Jr. Direct and indirect recognition: the role of MHC antigens in graft rejection. Immunol. Today 20, 77–82 ( 1999).
Toews, G.B., Bergstresser, P.R. & Streilein, J.W. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J. Immunol. 124, 445–453 (1980).
Noonan, F.P., Kripke, M.L., Pedersen, G.M. & Greene, M.I. Suppression of contact hypersensitivity in mice by ultraviolet irradiation is associated with defective antigen presentation. Immunology 43, 527–534 (1981).
Weiner, H.L. Oral tolerance; immune mechanisms and treatment of autoimmune diseases. Immunol. Today 18, 335–343 (1997).
Liblau, R., Tisch, R., Bercovici, N. & McDevitt, H.O. Systemic antigen in the treatment of T- cell-mediated autoimmune diseases. Immunol. Today 18, 599–604 ( 1997).
Magee, C.C. & Sayegh, M.H. Peptide-mediated immunosuppression. Curr. Opin. Immunol. 9, 669– 675 (1997).
Posselt, A.M., Barker, C.F., Friedman, A.L. & Naji, A. Prevention of autoimmune diabetes in the BB rat by intrathymic islet transplantation at birth. Science 256, 1321– 1324 (1992).
Bennett, S.R.M., Carbone, F.R., Toy, T., Miller, J.F.A.P. & Heath, W.R. B cells directly tolerize CD8+ T cells. J. Exp. Med. 188, 1977– 1983 (1998).
Morikawa, Y., Furotani, M., Kuribayashi, K., Matsuura, N. & Kakudo, K. The role of antigen-presenting cells in the regulation of delayed-type hypersensitivity. I. Spleen dendritic cells. Immunology 77, 81–87 (1992).
Morikawa, Y., Furotani, M., Kuribayashi, K., Matsuura, N. & Kakudo, K. The role of antigen- presenting cells in the regulation of delayed-type hypersensitivity. II. Epidermal Langerhans cells and peritoneal exudate macrophages. Cell. Immunol. 152, 200–210 (1993).
Cruz, P.D. Jr., Nixon-Fulton, J., Tigelaar, R.E. & Bergstresser, P.R. Disparate effects of in vitro UVB irradiation on intravenous immunization with epidermal cell subpopulations for the induction of contact hypersensitivity. J. Invest. Dermatol. 92, 160– 165 (1989).
Clare-Salzler, M., Brooks, J., Chai, A., Van Herle, K. & Anderson, C. Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer. J. Clin. Invest. 90, 741–748 (1992).
Khoury, S.J., Gallon, L., Verburg, R.R., et al. Ex vivo treatment of antigen-presenting cells with CTLA4Ig and encephalitogenic peptide prevents experimental autoimmune encephalomyelitis in the Lewis rat. J. Immunol. 157 , 3700–3705 (1996).
Zhang, H.-G., et al. Induction of specific T-cell tolerance by adenovirus- transfected, Fas ligand-producing antigen presenting cells. Nature Biotechnol. 16, 1045–1049 ( 1998).
Zhang, H. et al. Induction of specific T cell tolerance by Fas ligand- expressing antigen-presenting cells. J. Immunol. 162, 1423–1430 (1999).
Pulendran, B. et al. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA 96, 1036–1041 ( 1999).
Maldonatdo-López, R. et al. CD8α+ and CD8α+ subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189, 587–592 (1999).
Matsue, H., Bergstresser, P.R. & Takashima, A. Keratinocyte-derived IL-7 serves as a growth factor for dendritic epidermal T cells in mice. J. Immunol. 151, 6012–6019 (1993).
Matsue, H. et al. Dendritic cells undergo rapid apoptosis in vitro during antigen-specific interaction with CD4+ T cells. J. Immunol. 162, 5287–5298 (1999).
Acknowledgements
We thank D. Thiele for suggestions in histological evaluation of liver toxicity and J. Forman and P.R. Bergstresser for comments. This study was supported by NIH grants (RO1-AR35068, RO1-AR43777, and RO1-AI43262) and by CE.R.I.E.S. Award (A.T.).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matsue, H., Matsue, K., Walters, M. et al. Induction of antigen-specific immunosuppression by CD95L cDNA-transfected 'killer' dendritic cells. Nat Med 5, 930–937 (1999). https://doi.org/10.1038/11375
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/11375
This article is cited by
-
Local immunomodulation with Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance
Nature Materials (2018)
-
Synergistic suppression of autoimmune arthritis through concurrent treatment with tolerogenic DC and MSC
Scientific Reports (2017)
-
Dendritic cell co-transfected with FasL and allergen genes induces T cell tolerance and decreases airway inflammation in allergen induced murine model
Molecular Biology Reports (2011)
-
Membrane-bound CD95 ligand expressed on human antigen-presenting cells prevents alloantigen-specific T cell response without impairment of viral and third-party T cell immunity
Cell Death & Differentiation (2007)
-
Fas-ligand-expressing adenovirus-transfected dendritic cells decrease allergen-specific T cells and airway inflammation in a murine model of asthma
Journal of Molecular Medicine (2006)